HEARTFLOW INC (HTFL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for HTFL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HTFL | Continuing Director | 77 | [] | ["C"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CVS | [] | [] | 2023 | ||
| XOM | Former Chairman of the Board and CEO, Johnson & Johnson; Former Chairman of the Board and Chief Executive Officer | 71 | ["CVS Caremark","Global business leadership with operational experience at Johnson & Johnson as Chairman and Chief Executive Officer from 2002 to 2012","Vice Chairman from 2001 to 2002","Worldwide Chairman, Pharmaceuticals Group from 1998 to 2001","Business affiliations: Business Council (former Vice Chairman), Business Roundtable (former member), and Healthcare Leadership Council","Scientific, research and academic affiliations: Pharmaceutical Research and Manufacturers of America (former Chairman), Quinnipiac University Board of Trustees (Chairman), and CEO Roundtable on Cancer (former Chairman)","Current public company directorships: CVS Caremark (March 2013 to Present)","Previous public company directorships in last five years: JPMorgan Chase (March 2005 to April 2019); The Chubb Corporation (May 2013 to January 2016)","Other board experience: former Director of Johnson & Johnson (prior to 2015)"] | ["Audit","Finance"] | 2020 |
| JPM | Member | ["B","C"] | [] | 2019 | |
| CB | Director | 66 | ["Chairman and Chief Executive Officer of Johnson & Johnson", "expertise in international business operations", "vast knowledge of Johnson & Johnson\u2019s business, structure, history and culture"] | [] | 2015 |
| JNJ | Chairman, Board of Directors and Chief Executive Officer; Chairman of the Board | 63 | ["joined Johnson & Johnson in 1971","Vice Chairman of the Board in 2001","appointed Chairman/CEO in 2002","served in several sales, marketing and international management positions"] | ["Executive Committee"] | 2012 |
Biography sourced from the proxy statement filing.
William C. Weldon has served as Chair of our Board from June 2017 to May 2019 and since 2020 and also as a member of our Board since September 2014. Mr. Weldon is the former Chairman of the board and Chief Executive Officer of Johnson & Johnson (Nasdaq: JNJ), a global developer and manufacturer of healthcare products, having served in those positions from 2002 until his retirement in 2012. Mr. Weldon previously served in a variety of senior executive positions during his 41-year career with Johnson & Johnson until his appointment as Chairman of the board and Chief Executive Officer. Mr. Weldon previously served as a director of CVS Health Corporation (NYSE: CVS) until his retirement from that board in May 2023, Exxon Mobil Corporation (NYSE: XOM) until his retirement from that board in May 2021, JPMorgan Chase & Co. (NYSE: JPM) until his retirement from that board in May 2019, and The Chubb Corporation until its acquisition by ACE Limited in January 2016. Mr. Weldon has served on the board of Fairfax Financial Holdings Limited (TSX:FFH) since 2020, where he serves as chair of the governance and nominating committee. He is a member of various not-for-profit organizations and is also a member of the Board of Trustees for Quinnipiac University. Mr. Weldon received his B.A. in Biology from Quinnipiac University. We believe that Mr. Weldon s knowledge of the healthcare industry and his experience as chief executive officer and chairman of the board at Johnson & Johnson and on the boards of other publicly traded companies, which have exposed him to reporting and governance requirements, qualify him to serve on our Board.